scholarly article | Q13442814 |
P50 | author | Pascal Cosette | Q48604695 |
Emmanuelle Dé | Q57658572 | ||
Julie Hardouin | Q79177677 | ||
P2093 | author name string | Athanassios Tsakris | |
Demosthenes Makris | |||
Spyros Pournaras | |||
Aggeliki Poulou | |||
Ioulia Kristo | |||
Konstantina Dafopoulou | |||
Yassine Nait Chabane | |||
P2860 | cites work | A common mechanism of cellular death induced by bactericidal antibiotics | Q28246128 |
CspR, a cold shock RNA-binding protein involved in the long-term survival and the virulence of Enterococcus faecalis | Q28485694 | ||
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool | Q33552298 | ||
Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. | Q33901939 | ||
Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors | Q34064343 | ||
Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea | Q34123619 | ||
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production | Q34309451 | ||
Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii | Q34411048 | ||
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa | Q34555131 | ||
Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. | Q34764355 | ||
Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway | Q36364121 | ||
The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. | Q37124050 | ||
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system | Q37333088 | ||
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies | Q37996299 | ||
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. | Q38057841 | ||
A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics | Q38102548 | ||
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase | Q42168402 | ||
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli | Q42190018 | ||
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii | Q42689045 | ||
Global spread of carbapenem-resistant Acinetobacter baumannii | Q43227337 | ||
Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital | Q43756833 | ||
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii | Q45050449 | ||
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit | Q46907740 | ||
The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. | Q51791235 | ||
Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. | Q54377706 | ||
Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France | Q56572609 | ||
Peptide antibiotics | Q73073957 | ||
Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like | Q84974548 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Acinetobacter baumannii | Q3241189 |
cell death | Q2383867 | ||
P304 | page(s) | 828-832 | |
P577 | publication date | 2013-11-18 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii | |
P478 | volume | 58 |
Q55404021 | Acinetobacter baumannii: Epidemiological and Beta-Lactamase Data From Two Tertiary Academic Hospitals in Tshwane, South Africa. |
Q43350495 | Altered susceptibility to the bactericidal effect of photocatalytic oxidation by TiO2 is related to colistin resistance development in Acinetobacter baumannii |
Q55135895 | Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation. |
Q53703223 | Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. |
Q64124128 | Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii |
Q39514967 | Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae |
Q60919466 | Colistin Resistant : Genomic and Transcriptomic Traits Acquired Under Colistin Therapy |
Q41220559 | Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections |
Q28076261 | Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives |
Q36644871 | Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation |
Q57656298 | Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS |
Q40176183 | Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates |
Q87991381 | Fitness cost of mcr-1-mediated polymyxin resistance in Klebsiella pneumoniae |
Q50352226 | Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii |
Q35843094 | High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. |
Q35202480 | Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics |
Q47136007 | Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii |
Q38287949 | Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
Q53696497 | Phenotypic Changes Associated with Colistin Resistance due to Lipopolysaccharide Loss in Acinetobacter baumannii. |
Q38922536 | Polymyxin: Alternative Mechanisms of Action and Resistance. |
Q34552966 | Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes |
Q36438931 | Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria |
Q26749601 | Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial Resistance |
Q39190865 | Recent advances and perspectives in the design and development of polymyxins. |
Q41998459 | Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. |
Q40690118 | Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii |
Q35432662 | The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model |
Q40065990 | Transcriptional and mutational profiling of an aminoglycoside resistant Pseudomonas aeruginosa small colony variant. |
Search more.